Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

An opinionated take on NEJM highlights for March 2019

  • NEJM
Target assessment with genetic polymorphisms Please bear with me for a…

Read more